Although, the cause of the increase in serum copper concentrations among patients with cancer is not known, it was proposed to be related with the increased liver production of copper-containing ceruloplasmin as an inflammatory response to cancer or from a tumor-induced decrease in the catabolism of the serum ceruloplasmin(22). This evidence concerns the gene CP and neoplasm.